Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.

2018
  • Robin J Leach
  • Daniel W Lin
  • Jesse K McKenney
  • Ian M Thompson
  • Antonio Hurtado-Coll
  • Martin E Gleave
  • Heidi Auman
  • Ziding Feng
  • Ladan Fazli
  • James D Brooks
  • Peter R Carroll
  • Debashis Sahoo
  • Peter S Nelson
  • Wei Wei
  • Lawrence D True
  • Dean A Troyer
  • Jeff Simko
Oncotarget